Home/Filings/4/0001209191-19-057941
4//SEC Filing

Rajpal Rajesh K. 4

Accession 0001209191-19-057941

CIK 0001343304other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 4:33 PM ET

Size

26.2 KB

Accession

0001209191-19-057941

Insider Transaction Report

Form 4
Period: 2019-11-21
Rajpal Rajesh K.
Chief Medical Officer
Transactions
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2019-11-215,5350 total
    Exercise: $1.34Exp: 2026-03-24Common Stock (5,535 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2019-11-214,2220 total
    Exercise: $2.14Exp: 2028-01-30Common Stock (4,222 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2019-11-2114,0160 total
    Exercise: $2.14Exp: 2028-01-30Common Stock (14,016 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2019-11-2144,4940 total
    Exercise: $12.73Exp: 2029-01-08Common Stock (44,494 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2019-11-211410 total
    Exercise: $46.01Exp: 2021-08-12Common Stock (141 underlying)
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2019-11-21700 total
    Exercise: $35.42Exp: 2023-04-21Common Stock (70 underlying)
  • Disposition to Issuer

    Common Stock

    2019-11-21127,6660 total
  • Disposition to Issuer

    Employee Stock Option (right to buy)

    2019-11-2120,3710 total
    Exercise: $3.69Exp: 2028-07-17Common Stock (20,371 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2019-11-212120 total
    Common Stock (212 underlying)
  • Disposition to Issuer

    Restricted Stock Units

    2019-11-2114,1300 total
    Common Stock (14,130 underlying)
Footnotes (4)
  • [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated as of August 7, 2019, by and among Avedro, Inc. (the "Issuer"), Glaukos Corporation ("Parent") and Atlantic Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), on November 21, 2019, Merger Sub merged with and into the Issuer (the "Merger") with the Issuer continuing as the surviving corporation. Pursuant to the terms of the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of common stock of the Issuer ("Issuer Common Stock") that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive 0.365 of a share of Parent's common stock ("Parent Common Stock"). The closing price of shares of the Parent Common Stock on November 21, 2019 was $63.07 per share.
  • [F2]At the Effective Time, each outstanding and unexercised option to purchase Issuer Common Stock (whether vested or unvested) immediately prior to the Effective Time, was assumed by Parent and converted into an option to purchase shares of Parent Common Shares (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such option of Issuer.
  • [F3]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
  • [F4]At the Effective Time, each outstanding restricted stock unit ("Issuer RSU") (excluding any Issuer RSU that vested prior to or as a result of the consummation of the Merger and which settled in shares of Issuer Common Stock that were converted into the right to receive shares of Parent Common Stock as a result of the Merger) was assumed by Parent and converted into the right to receive shares of Parent Common Stock (rounded down to the nearest whole share) using a conversion ratio designed to preserve the intrinsic value of such Issuer RSU.

Issuer

AVEDRO INC

CIK 0001343304

Entity typeother

Related Parties

1
  • filerCIK 0001767449

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 4:33 PM ET
Size
26.2 KB